C4X Discovery Holdings (C4XD) Share Price

Health Care Sector


NOTE: This is based on 2 open tips for C4X Discovery Holdings (C4XD)


C4X Discovery Holdings (C4XD)
Latest Quote Price

12.00p

C4X Discovery Holdings (C4XD)
Price Change (%)

8.22%


Latest Bid : 10.00p Latest Ask : 10.80p
High Today : 10.20p Low Today : 8.30p
This Years High : 21.45p This Years Low : 7.80p
Volume : 3,230,441 MKT Cap : £27.22M
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only


C4X Discovery Holdings (C4XD) Overview

C4X Discovery (C4XD) is a pioneering Drug Discovery company, combining scientific expertise with cutting-edge technologies to efficiently deliver world‑leading medicines. We have a highly valuable and differentiated approach to Drug Discovery through our enhanced molecular design and patient stratification capabilities, generating small molecule drug candidates across multiple disease indications focused on immuno-inflammation. We are advancing our internal portfolio which ranges from early-stage target opportunities to late-stage Drug Discovery programmes and we have two commercially partnered programmes with Sanofi and AstraZeneca, and one clinical stage candidate which has been acquired by Indivior.

C4X Discovery Holdings (C4XD) Latest Tips

Type Tipster SectorScore Start date Performance
Buy Shore Capital Premium Only 2023-12-14 14:30:00 14/12/2023 11.11%
Buy Panmure Gordon Premium Only 2017-02-21 10:00:00 21/02/2017 -87.02%

You are missing Premium Content from this chart

Please Log In to a premium account or Sign Up today to view premium content.


C4X Discovery Holdings (C4XD) Active Short Positions

Fund Manager Position Date
No active short positions

See more short positions...


Latest Bid : 10.00p Latest Ask : 10.80p
High Today : 10.20p Low Today : 8.30p
This Years High : 21.45p This Years Low : 7.80p
Volume : 3,230,441 MKT Cap : £27.22M

C4X Discovery Holdings Overview

C4X Discovery (C4XD) is a pioneering Drug Discovery company, combining scientific expertise with cutting-edge technologies to efficiently deliver world‑leading medicines. We have a highly valuable and differentiated approach to Drug Discovery through our enhanced molecular design and patient stratification capabilities, generating small molecule drug candidates across multiple disease indications focused on immuno-inflammation. We are advancing our internal portfolio which ranges from early-stage target opportunities to late-stage Drug Discovery programmes and we have two commercially partnered programmes with Sanofi and AstraZeneca, and one clinical stage candidate which has been acquired by Indivior.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Latest C4X Discovery Holdings Tips

Type Tipster SectorScore Start date Performance
Buy Shore Capital Premium Only 2023-12-14 14:30:00 14/12/2023 11.11%
Buy Panmure Gordon Premium Only 2017-02-21 10:00:00 21/02/2017 -87.02%